Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
Public ClinicalTrials.gov record NCT01852370. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Bilateral Orthotopic Lung Transplant in Tandem With CD3+ and CD19+ Cell Depleted Bone Marrow Transplant From Partially HLA-Matched Cadaveric Donors
Study identification
- NCT ID
- NCT01852370
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Paul Szabolcs
- Other
- Enrollment
- 16 participants
Conditions and interventions
Conditions
- Chronic Granulomatous Disease (CGD)
- Common Variable Immune Deficiency (CVID)
- Hyper IgE Syndromes
- Hyper IgM Deficiencies
- Immunodeficiency With Predominant T-cell Defect, Unspecified
- Mendelian Susceptibility to Mycobacterial Disease
- Severe Chronic Neutropenia
- Severe Combined Immunodeficiency (SCID)
- Wiskott-Aldrich Syndrome
Interventions
- CD3/CD19 negative allogeneic hematopoietic stem cells Biological
Biological
Eligibility (public fields only)
- Age range
- 5 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2013
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2027
- Last update posted
- Dec 14, 2025
2013 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh | Pennsylvania | 15224 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01852370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01852370 live on ClinicalTrials.gov.